Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story Markets 29 d ago
argenx SE (ARGX) Won Its Phase 3 Myositis Trial. How Much Does the Subgroup Miss Matter? Markets 33 d ago also on SE
argenx SE (ARGX) Discusses Positive Phase 3 ALKIVIA Trial Results for VYVGART Hytrulo in Autoimmune Myositis - Slideshow Markets 34 d ago also on SE
Argenx shares jump after positive Phase 3 results in autoimmune myositis trial Markets 37 d ago 3 sources
Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated? Markets 22 d ago
Could argenx SE (ARGX)’s Global Scale Give it an Edge Over Zai Lab Limited American Depositary Shares (ZLAB)? Markets 34 d ago also on ZLAB SE
Hedge Funds Favor argenx (ARGX) Over Forte Biosciences, Inc. (FBRX): Argenx Agrees to Buy Forte Biosciences Markets 44 d ago also on VNTXF FBRX